We are live on
!
Find out more
CGL
Clarius Group LLC Portfolio holdings
AUM
$1.75B
1-Year Est. Return
19.04%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$631M
AUM Growth
+$86.3M
(+16%)
Cap. Flow
+$27.4M
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
54.01%
Holding
309
New
31
Increased
145
Reduced
97
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$7.61M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$7.3M |
| 3 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$6.97M |
| 4 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$5.29M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$4.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$11.8M |
| 2 |
Vanguard Growth ETF
VUG
|
+$2.45M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$2.18M |
| 4 |
iShares Core S&P US Growth ETF
IUSG
|
+$1.48M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.98% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Communication Services | 5% |
| 5 | Financials | 4.86% |
Similar funds
A
CB
JCM
GH
MPM
NAS
RC
LGWM
Clarius Group LLC's Q4 2019 Portfolio in Review
As of Q4 2019, Clarius Group LLC held 309 positions worth $631M, up 16% from $545M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Clarius Group LLC deployed $27.4M of net new capital in Q4 2019, opening 31 new positions and adding to 145 existing holdings. Its largest new stake was Sage Therapeutics: 35,500 shares worth $2.66M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $11.8M trimmed.
- Clarius Group LLC's largest Q4 2019 buy was Sage Therapeutics: 35,500 shares worth $2.66M.
- Clarius Group LLC added most to Invesco Russell 1000 Dynamic Multifactor ETF in Q4 2019, an estimated $7.61M increase.
- Clarius Group LLC's biggest Q4 2019 reduction was Microsoft, cutting an estimated $11.8M.
- Clarius Group LLC fully exited Berkshire Hathaway Class A in Q4 2019, selling an estimated $2.18M.
- Clarius Group LLC's ten largest holdings make up 54% of its $631M portfolio in Q4 2019.
- Clarius Group LLC opened 31 new positions and closed 13 in Q4 2019.
- Clarius Group LLC's portfolio value rose 16% quarter-over-quarter to $631M.
Based on Clarius Group LLC's 13F filing for Q4 2019, filed 22 Jan 2020.